GH
AVNS

GAM Holding’s Avanos Medical AVNS Stock Holding History

GAM Holding’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-8,162
Closed -$467K – 880
2018
Q2 		$467K Buy
+8,162
New +$431K 0.02% 681
2017
Q3 		– Sell
-26,150
Closed -$1.03M – 572
2017
Q2 		$1.03M Sell
26,150
-24,424
-48% -$923K 0.02% 641
2017
Q1 		$1.93M Buy
50,574
+24,424
+93% +$952K 0.03% 514
2016
Q4 		$967K Sell
26,150
-1,970
-7% -$70.4K 0.02% 623
2016
Q3 		$975K Sell
28,120
-28,120
-50% -$985K 0.02% 620
2016
Q2 		$1.83M Buy
56,240
+28,120
+100% +$861K 0.03% 540
2016
Q1 		$808K Hold
28,120
– – 0.01% 651
2015
Q4 		$939K Hold
28,120
– – 0.01% 712
2015
Q3 		$800K Sell
28,120
-4,375
-13% -$153K 0.01% 745
2015
Q2 		$1.32M Hold
32,495
– – 0.02% 668
2015
Q1 		$1.6M Sell
32,495
-9,000
-22% -$417K 0.02% 585
2014
Q4 		$1.89M Buy
+41,495
New +$1.63M 0.03% 521

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

GAM Holding's AVNS Position: Q3 2018 in Review

GAM Holding sold out of Avanos Medical (AVNS) in Q3 2018, closing a stake of 8,162 shares — an estimated $467K sold.

GAM Holding first reported a position in AVNS in Q4 2014 and held it in 12 quarters. The position peaked at $1.93M in Q1 2017. 387 funds tracked by Wall St. Rank hold AVNS as of Q3 2018.

  • GAM Holding reported no remaining Avanos Medical position as of Q3 2018 after selling out during the quarter.
  • GAM Holding sold 8,162 Avanos Medical shares in Q3 2018, an estimated $467K.
  • GAM Holding first reported a position in Avanos Medical in Q4 2014 and held it in 12 quarters.
  • GAM Holding's Avanos Medical position peaked at $1.93M in Q1 2017.
  • 387 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2018.

Based on GAM Holding's 13F filing for Q3 2018, filed 13 Nov 2018.